Saturday 17 November 2018
Home      All news      Contact us      English
sputniknews - 1 month ago

Russia s Biocad Awaits Approval of Drug Based on 2018 Nobel Prize Research

MOSCOW (Sputnik) - Russian biotechnology company Biocad expects its cancer medicine that is based on research by 2018 Nobel laureates to be approved in the second quarter of next year, the Biocad president told Sputnik in an interview.

Related news

Latest News
Hashtags:   

Russia

 | 

Biocad

 | 

Awaits

 | 

Approval

 | 

Based

 | 

Nobel

 | 

Prize

 | 

Research

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources